IONELA GUG: Open Payments
NPI 1598395857 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 11 payments from 10 companies in 2025. Trend: 2023 $754 · 2024 $509 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Genentech USA, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $23 |
| Incyte Corporation | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Caris MPI, Inc. | 1 | $14 |
Products named: REBLOZYL, AYVAKIT, FRUZAQLA, Polivy, VENCLEXTA, JAKAFI, RYBREVANT, Nubeqa.
Industry payments across TX — which companies pay providers there.
